Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Nutrient digestibility is a physiological measure representing the proportion of ingested nutrients that are broken down and absorbed by the gastrointestinal tract into the systemic circulation (FAO, 2013). It is an aggregate outcome of various biochemical and mechanical processes, including mastication, enzymatic hydrolysis, and transport across the intestinal epithelium (StatPearls, 2023). Rather than being a discrete molecular target like a receptor or enzyme, nutrient digestibility serves as a clinical endpoint for assessing gastrointestinal health and metabolic efficiency. Therapeutic interventions often target specific components of this process; for instance, lipase inhibitors like Orlistat reduce fat digestibility to treat obesity by inhibiting gastric and pancreatic lipases (Guerciolini, 1997), while enzyme replacements enhance it in conditions like exocrine pancreatic insufficiency (NIH, 2022). Understanding digestibility is crucial for managing malabsorptive diseases such as Celiac disease or Crohn's disease, where structural damage to the intestinal mucosa impairs nutrient uptake (Mayo Clinic, 2023).
Nutrient digestibility is a physiological outcome rather than a single molecular target. It is modulated by pharmacological agents that either inhibit digestive enzymes (e.g., Orlistat for lipases, Acarbose for alpha-glucosidases), replace deficient endogenous enzymes (e.g., pancrelipase), or alter gastrointestinal transit time and pH to facilitate or hinder the breakdown and transport of macronutrients across the intestinal mucosa (StatPearls, 2023; Guerciolini, 1997).
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Nutrient digestibility.